Oncolytics Biotech Inc (ONCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 29,798 | 13,031 | 11,733 | 8,974 | 24,796 |
| Marketable Securities | N/A | 5,081 | 10,200 | 15,747 | N/A |
| Receivables | 470 | 416 | 540 | 401 | 381 |
| TOTAL | $33,790 | $23,054 | $25,326 | $27,448 | $29,273 |
| Non-Current Assets | |||||
| PPE Net | 223 | 237 | 251 | 274 | 291 |
| Other Non-Current Assets | 338 | 486 | 538 | 995 | 287 |
| TOTAL | $561 | $722 | $789 | $1,269 | $578 |
| Total Assets | $34,350 | $23,776 | $26,115 | $28,717 | $29,850 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,381 | 1,759 | 1,650 | 2,808 | 2,545 |
| Other current liabilities | 3,943 | 114 | 36 | 61 | 38 |
| TOTAL | $7,466 | $1,972 | $1,825 | $3,035 | $2,809 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 5,257 | 5,263 | 5,254 | 5,298 | 5,284 |
| TOTAL | $5,257 | $5,263 | $5,254 | $5,298 | $5,284 |
| Total Liabilities | $12,723 | $7,235 | $7,079 | $8,332 | $8,093 |
| Shareholders' Equity | |||||
| Common Shares | 319,604 | 307,505 | 302,637 | 310,788 | 305,000 |
| Retained earnings | -329,463 | -321,418 | -313,929 | -321,719 | -313,909 |
| Other shareholders' equity | 488 | 412 | 487 | 509 | 554 |
| TOTAL | $21,627 | $16,541 | $19,035 | $20,385 | $21,758 |
| Total Liabilities And Equity | $34,350 | $23,776 | $26,114 | $28,717 | $29,850 |